Skip to content
Thursday, November 19, 2026 Market moodBearish−19.8
Sign in
GlideslopeGlideslopeGlideslope AI-powered market news
GlideslopeGlideslopeGlideslope
Breaking
THE DAILY CALLER Hegseth Announces ‘Renewed Military Partnership’ With Venezuela, Promises More Strikes On… Neutral CNBC TOP STORIES Takaichi gets chilly reception in China on first Japan leader visit since 2019 Neutral THE DAILY CALLER Outgoing GOP Senator Thom Tillis Blocks Bill That Would Ban Former Senators From Lobbying Bearish CNBC FINANCE Trump holds talks separately with Putin and Xi ahead of their historic trilateral meeting Neutral BBC BUSINESS Increase in direct cremations since pandemic Bearish BBC BUSINESS Leftover pumpkins help deliver 1,000th free meal Neutral FOREIGN POLICY Why Did Trump Attend ASEAN? Neutral CNBC TOP STORIES The 'exceptional' dollar scenario that forced Deutsche Bank to change its FX forecasts Bullish BUSINESS INSIDER Trump surges to the top of Chinese social media just by showing up Strong Bullish COINTELEGRAPH Senators warn GENIUS Act rules could push stablecoin firms toward federal oversight Bearish NEW YORK TIMES BUSINESS What Nvidia’s Interim CEO, Colette Kress, Said to Employees After Jensen Huang’s Resignat… Neutral COINTELEGRAPH Binance hackers stole 192 tokens across 11 networks, court docs show Pessimistic BUSINESS INSIDER Workers are bribing their bosses with Instagram likes to get a day off to play 'GTA 6' Neutral CNBC BUSINESS Walmart is set to report earnings before the bell. Here's what to expect Bullish NEW YORK TIMES BUSINESS Have High Gas Prices Made You Change How You Drive? Tell Us About It. Neutral NEW YORK TIMES BUSINESS How the War in Iran Will Remake the Global Energy Order Strong Bullish WSJ ECONOMY Bank of Japan’s Ueda Vows to Keep Careful Eye on Fed Moves Neutral MOTOR1 Lamborghini's New 907-HP Spyder Has A Roof That Actually Improves Handling Neutral CBS NEWS What we know about Trump's meeting with China's Xi, Russia's Putin Neutral CNBC TRAVEL 'Parasite' backer and other South Korean media, gaming and travel stocks rally on China t… Strong Bullish THE DAILY CALLER Hegseth Announces ‘Renewed Military Partnership’ With Venezuela, Promises More Strikes On… Neutral CNBC TOP STORIES Takaichi gets chilly reception in China on first Japan leader visit since 2019 Neutral THE DAILY CALLER Outgoing GOP Senator Thom Tillis Blocks Bill That Would Ban Former Senators From Lobbying Bearish CNBC FINANCE Trump holds talks separately with Putin and Xi ahead of their historic trilateral meeting Neutral BBC BUSINESS Increase in direct cremations since pandemic Bearish BBC BUSINESS Leftover pumpkins help deliver 1,000th free meal Neutral FOREIGN POLICY Why Did Trump Attend ASEAN? Neutral CNBC TOP STORIES The 'exceptional' dollar scenario that forced Deutsche Bank to change its FX forecasts Bullish BUSINESS INSIDER Trump surges to the top of Chinese social media just by showing up Strong Bullish COINTELEGRAPH Senators warn GENIUS Act rules could push stablecoin firms toward federal oversight Bearish NEW YORK TIMES BUSINESS What Nvidia’s Interim CEO, Colette Kress, Said to Employees After Jensen Huang’s Resignat… Neutral COINTELEGRAPH Binance hackers stole 192 tokens across 11 networks, court docs show Pessimistic BUSINESS INSIDER Workers are bribing their bosses with Instagram likes to get a day off to play 'GTA 6' Neutral CNBC BUSINESS Walmart is set to report earnings before the bell. Here's what to expect Bullish NEW YORK TIMES BUSINESS Have High Gas Prices Made You Change How You Drive? Tell Us About It. Neutral NEW YORK TIMES BUSINESS How the War in Iran Will Remake the Global Energy Order Strong Bullish WSJ ECONOMY Bank of Japan’s Ueda Vows to Keep Careful Eye on Fed Moves Neutral MOTOR1 Lamborghini's New 907-HP Spyder Has A Roof That Actually Improves Handling Neutral CBS NEWS What we know about Trump's meeting with China's Xi, Russia's Putin Neutral CNBC TRAVEL 'Parasite' backer and other South Korean media, gaming and travel stocks rally on China t… Strong Bullish
Story 02 of 8
  1. 01Ukraine Regains Full Starlink Speed After Musk-Ordered Throttling Lifted
  2. 02Moderna Stock Crashes on Cancer Vaccine Data Leak Despite Positive Phase 3 Results
  3. 03Major Banks Restrict AI Agent Access to Customer Accounts Amid Security Breach Fears
  4. 04Audi Plans Georgia Factory as Trump Tariffs Force VW to Shift Production Onshore
  5. 05Truckload Rates Surge Above 10% as Carriers Push Through Sustained Price Increases
  6. 06Federal Rescheduling of Marijuana to Schedule 3 Opens $50 Billion Industry to Mainstream Capital
  7. 07Port Milwaukee Faces Tariff Whiplash as Trump Trade Policy Disrupts Goods Flow
  8. 08Small Businesses Report Margin Squeeze From Trump Tariffs and Persistent Inflation
Healthcare

Moderna Stock Crashes on Cancer Vaccine Data Leak Despite Positive Phase 3 Results

Moderna Stock Crashes on Cancer Vaccine Data Leak Despite Positive Phase 3 Results

What’s happening

Moderna's stock plunged after Phase 3 trial data for its personalized cancer vaccine (developed with Merck) leaked ahead of official release, though the full dataset released later showed positive efficacy signals. The market reaction suggests investors punished the leak itself and questioned whether the results met the bar set by earlier hype.

Market impact

Moderna (MRNA) has been a momentum darling this year; the stock's sharp reversal on positive data signals investor skepticism about valuation and execution risk. The leak also raises governance concerns, potentially inviting regulatory scrutiny and analyst downgrades if the market perceives the data as merely meeting, not exceeding, expectations.

Broader implications

The cancer vaccine represents Moderna's pivot beyond COVID; a stumble here undermines the narrative that the company can diversify revenue streams. Approval is likely, but the market's tepid response suggests investors are pricing in competitive pressure from other cancer immunotherapy players and questions about real-world adoption rates.

Sources (3)

The articles Pulse read to write this story
  1. Moderna's cancer vaccine is 'likely' to get approved. Skeptics question if it will be the best option.
  2. Moderna shares plunge after leak of cancer vaccine data despite positive results
  3. Moderna's stock tumbles after reported leak of data for cancer vaccine

Written by Pulse AI from the articles above. Always check the original reporting before acting on it.

● MACRO ANALYST

Apex+

Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.

LOG IN / SUBSCRIBE